Literature DB >> 32194690

MicroRNA-107 may regulate lung cancer cell proliferation and apoptosis by targeting TP53 regulated inhibitor of apoptosis 1.

Peng Cai1, Jingjing Li1, Guiming Chen1, Bing Peng1, Liuyang Yu1, Bolin Zhao1, Yi Yu2.   

Abstract

Lung cancer causes over 1.6 million mortalities worldwide annually. MicroRNAs (miRs) are involved in various types of cancer-associated processes. The present study investigated the possible mechanism of miR-107 in the development of lung cancer in order to identify novel targets for clinical treatment. The expression levels of miR-107 and its putative target gene TP53 regulated inhibitor of apoptosis 1 (TRIAP1) were measured in lung cancer tumor tissues and non-tumor adjacent tissues. Subsequently, the association between TRIAP1 and miR-107 was investigated using a dual-luciferase reporter assay. Following transfection, the effects of miR-107 and TRIAP1 on the proliferation and apoptosis of lung cancer cell lines in vitro were investigated using Cell Counting Kit-8 and flow cytometry assays, respectively. Furthermore, the regulatory effect of miR-107 on the expression levels of TRIAP1 and associated proteins was analyzed using a western blot assay. The results revealed lower expression levels of miR-107 and higher expression levels of TRIAP1 in lung cancer tumor tissues compared with non-tumor adjacent tissues. The dual-luciferase reporter assay demonstrated that TRIAP1 is a target gene of miR-107. Additionally, the results revealed that overexpression of miR-107 resulted in a lower proliferation rate and higher apoptosis rate of A549 cells, compared with the negative control (NC) and control groups (P<0.01). The variation of cell proliferation and apoptosis induced by miR-107 mimics was reversed by co-transfection with pcDNA3.1-TRIAP1. Furthermore, the expression levels of cyclin D1 and proliferating cell nuclear antigen were markedly decreased in the miR-107 mimics group compared with the NC group (P<0.01). The expression levels of BCL2 associated X apoptosis regulator, tumor protein p53 and caspase 3 were upregulated and the expression levels of TRIAP1 and BCL2 apoptosis regulator were significantly reduced in the miR-107 mimics group compared with the NC group (P<0.01). The results of the present study suggested that miR-107 regulates lung cancer cell proliferation and apoptosis by targeting TRIAP1.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  TP53 regulated inhibitor of apoptosis 1; lung cancer; microRNA-107; proliferation and apoptosis

Year:  2020        PMID: 32194690      PMCID: PMC7039174          DOI: 10.3892/ol.2020.11248

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  35 in total

1.  miR-107 and miR-25 simultaneously target LATS2 and regulate proliferation and invasion of gastric adenocarcinoma (GAC) cells.

Authors:  Mingjun Zhang; Xiaolei Wang; Wanhu Li; Yongchun Cui
Journal:  Biochem Biophys Res Commun       Date:  2015-03-28       Impact factor: 3.575

2.  MiR-550a-3p promotes non-small cell lung cancer cell proliferation and metastasis through down-regulating TIMP2.

Authors:  J-Z Yang; L Bian; J-G Hou; H-Y Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-07       Impact factor: 3.507

Review 3.  Targeting the p53 signaling pathway in cancer therapy - the promises, challenges and perils.

Authors:  Alexander H Stegh
Journal:  Expert Opin Ther Targets       Date:  2012-01-12       Impact factor: 6.902

4.  P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis.

Authors:  Munekazu Yamakuchi; Craig D Lotterman; Clare Bao; Ralph H Hruban; Baktiar Karim; Joshua T Mendell; David Huso; Charles J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

Review 5.  Lung cancer epidemiology: contemporary and future challenges worldwide.

Authors:  Joanna Didkowska; Urszula Wojciechowska; Marta Mańczuk; Jakub Łobaszewski
Journal:  Ann Transl Med       Date:  2016-04

6.  MicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cells.

Authors:  Bowen Du; Zhe Wang; Xin Zhang; Shipeng Feng; Guoxin Wang; Jianxing He; Biliang Zhang
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

7.  In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt/β-catenin signaling pathway in osteosarcoma.

Authors:  Zhi-Cai Zhang; Jian-Xiang Liu; Zeng-Wu Shao; Fei-Fei Pu; Bai-Chuan Wang; Qiang Wu; Yu-Kun Zhang; Xian-Lin Zeng; Xiao-Dong Guo; Shu-Hua Yang; Tong-Chuan He
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

8.  miR-363-3p inhibits tumor growth by targeting PCNA in lung adenocarcinoma.

Authors:  Yahong Wang; Ting Chen; Haili Huang; Yun Jiang; Lawei Yang; Ziying Lin; Huijuan He; Tie Liu; Bin Wu; Jie Chen; David W Kamp; Gang Liu
Journal:  Oncotarget       Date:  2017-03-21

9.  A Novel Serum 4-microRNA Signature for Lung Cancer Detection.

Authors:  Ernest Nadal; Anna Truini; Asuka Nakata; Jules Lin; Rishindra M Reddy; Andrew C Chang; Nithya Ramnath; Noriko Gotoh; David G Beer; Guoan Chen
Journal:  Sci Rep       Date:  2015-07-23       Impact factor: 4.379

10.  Overexpression of Mitochondria Mediator Gene TRIAP1 by miR-320b Loss Is Associated with Progression in Nasopharyngeal Carcinoma.

Authors:  Yingqin Li; Xinran Tang; Qingmei He; Xiaojing Yang; Xianyue Ren; Xin Wen; Jian Zhang; Yaqin Wang; Na Liu; Jun Ma
Journal:  PLoS Genet       Date:  2016-07-18       Impact factor: 5.917

View more
  3 in total

1.  miR-107 Inhibits the Proliferation of Gastric Cancer Cells In vivo and In vitro by Targeting TRIAP1.

Authors:  Jiexin Yan; Lu Dai; Jun Yuan; Min Pang; Yueqiu Wang; Lang Lin; Yawei Shi; Fuli Wu; Rongping Nie; Qiuling Chen; Lei Wang
Journal:  Front Genet       Date:  2022-04-11       Impact factor: 4.772

2.  PCGEM1 promotes proliferation, migration and invasion in prostate cancer by sponging miR-506 to upregulate TRIAP1.

Authors:  He Liu; Xin He; Tianjiao Li; Yi Qu; Lina Xu; Yingnan Hou; Yao Fu; Hongzhi Wang
Journal:  BMC Urol       Date:  2022-02-02       Impact factor: 2.264

3.  PSME4 Activates mTOR Signaling and Promotes the Malignant Progression of Hepatocellular Carcinoma.

Authors:  Sijia Ge; Hua Huang; Wei Huang; Ran Ji; Jing Chen; Shuzhen Wu; Liyang Wang; Tianxin Huang; Yu Sheng; Haiou Yan; Cuihua Lu; Lin Ma
Journal:  Int J Gen Med       Date:  2022-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.